SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-12-056458
Filing Date
2012-10-16
Accepted
2012-10-16 18:02:19
Documents
1
Period of Report
2012-08-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v325786_4.html 4  
1 OWNERSHIP DOCUMENT v325786_4.xml 4 12872
  Complete submission text file 0001144204-12-056458.txt   14217
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
SILVERSTEIN JONATHAN (Reporting) CIK: 0001171005 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 121146985

Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations